BrightPath Biotherapeutics Co., Ltd.

TSE:4594.T

50 (JPY) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 0.0280.0050.0230.0280.0160.0515.050.0730.10615.0780.0670.0510.2120.6590.4251.1010.3198.5010.841.1360.8231.18712.18620.306122.129107.77663.95192.04590.63898.182114.4123.888193.142209.443197.209209.592206.312
Cost of Revenue 0.0070.0870.0050.0070.0040.6131.2380.0180.0263.2350.0170.0120.0530.4240.1070.5350.0793.510.210.5420.2050.5553.4064.51162.2375.11662.11590.10787.836101.879110.125121.491191.418197.356185.29196.073192.938
Gross Profit 0.021-0.0820.0180.0210.012-0.5623.8120.0550.0811.8430.050.0390.1590.2350.3180.5660.244.9910.630.5940.6180.6328.7815.79559.89932.661.8361.9382.802-3.6974.2752.3971.72412.08711.91913.51913.374
Gross Profit Ratio 0.75-16.40.7830.750.75-11.020.7550.7530.7550.7850.7460.7650.750.3570.7480.5140.7520.5870.750.5230.7510.5320.720.7780.490.3030.0290.0210.031-0.0380.0370.0190.0090.0580.060.0650.065
Reseach & Development Expenses 0127.978283.687171.031192.86179.599345.148193.53450.196323.613272.247238.391301.596361.074000000000001,2530008160000000
General & Administrative Expenses 000000000000000000000000074000670000000
Selling & Marketing Expenses 00000000000000000000000007580003410000000
SG&A 326.99879.847112.67186.125100.53964.34667.78861.98991.12881.28971.11871.8692.88764.264000000004634444578324864262644080000000
Other Expenses -326.9980.1-0.0900.186-0.24400.2380.247414.1590.0450.0360.008442.917518.1520.0190.0790.329481.654421.223-0.028-21.5833.6837.5370.0980.011-0.4070.3030.01216.193-3.216-0.4230.0080.0921.0040.00312.856
Operating Expenses 326.998207.825396.62257.156293.447248.125417.116259.699545.503414.159352.297318.936402.732442.917518.152363.956409.136507.354481.654421.223423.951386.123462.746444.23457.556424.863485.445425.786264.874410.643234.645283.281189.68213.904192.145329.806303.794
Operating Income -326.977-207.907-396.604-257.134-293.435-248.688-413.303-259.645-545.423-402.316-352.246-318.898-402.573-442.682-517.834-363.39-408.896-502.363-481.024-420.629-423.333-385.489-453.967-428.435-397.657-392.203-483.609-423.847-262.073-414.34-230.369-280.885-187.956-201.818-180.225-316.288-290.419
Operating Income Ratio -11,677.75-41,581.4-17,243.652-9,183.357-18,339.688-4,876.235-81.842-3,556.781-5,145.5-26.682-5,257.403-6,252.902-1,898.929-671.748-1,218.433-330.054-1,281.806-59.095-572.648-370.272-514.378-324.759-37.253-21.099-3.256-3.639-7.562-4.605-2.891-4.22-2.014-2.267-0.973-0.964-0.914-1.509-1.408
Total Other Income Expenses Net -2.969-5.935-2.764-0.557-1.846-11.088-0.862-1.926-2.798-2.602-1.897-1.4290.191.84514.812-0.635-0.433-21.754-18.6460.8647.025-28.2142.209-4.708-184.267-8.67-3.6220.801-0.0689.676-8.894-1.617-2.5430.832-17.8090.16912.581
Income Before Tax -329.946-213.842-399.368-257.691-295.281-259.776-414.165-261.571-548.221-404.918-354.144-320.327-402.383-440.838-503.021-364.025-409.33-524.117-499.67-419.765-416.309-413.704-451.758-433.142-581.925-400.874-487.231-423.047-262.14-404.664-239.264-282.501-190.499-200.985-198.035-316.118-277.839
Income Before Tax Ratio -11,783.786-42,768.4-17,363.826-9,203.25-18,455.063-5,093.647-82.013-3,583.164-5,171.896-26.855-5,285.731-6,280.922-1,898.033-668.95-1,183.579-330.631-1,283.166-61.654-594.845-369.511-505.843-348.529-37.072-21.331-4.765-3.72-7.619-4.596-2.892-4.122-2.091-2.28-0.986-0.96-1.004-1.508-1.347
Income Tax Expense 0.4750.4750.4750.4750.4750.4750.4750.4750.4750.6050.6050.6050.6050.6050.6050.6050.605-4.0540.4920.4920.9830.6660.8470.8471.4280.8560.8480.9482.4720.5610.6843.4020.424-0.0660.8110.430.312
Net Income -330.421-214.317-399.843-258.166-295.756-260.251-414.64-262.046-548.696-405.523-354.749-320.932-402.988-441.443-503.626-364.63-409.935-520.063-500.162-420.257-417.292-414.371-452.604-433.989-583.354-401.73-488.08-423.994-263.338-400.779-236.056-285.903-190.923-200.918-198.847-316.548-278.151
Net Income Ratio -11,800.75-42,863.4-17,384.478-9,220.214-18,484.75-5,102.961-82.107-3,589.671-5,176.377-26.895-5,294.761-6,292.784-1,900.887-669.868-1,185.002-331.181-1,285.063-61.177-595.431-369.945-507.038-349.091-37.141-21.372-4.777-3.727-7.632-4.606-2.905-4.082-2.063-2.308-0.989-0.959-1.008-1.51-1.348
EPS -4.66-3.17-6.32-4.1-4.7-4.14-6.73-4.52-9.75-7.56-6.77-6.27-7.93-8.84-10.17-8.47-9.52-12.35-11.9-10.01-9.94-9.87-10.81-10.37-13.94-9.79-13.11-11.39-7.08-11.02-7.38-8.93-5.97-6.32-7.86-12.51-10.99
EPS Diluted -4.66-3.17-6.32-4.1-4.7-4.14-6.73-4.45-9.75-7.34-6.77-6.13-7.93-8.68-9.91-8.47-9.52-12.07-11.61-10.01-9.94-9.87-10.78-10.37-13.94-9.6-11.66-11.39-7.08-10.77-6.34-8.93-5.97-6.28-6.21-12.51-10.99
EBITDA -326.977-207.822-393.249-257.135-292.029-265.3-413.304-259.644-545.424-408.699-350.663-318.127-404.095-446.112-531.911-369.222-406.98-478.344-463.674-420.629-428.838-377.261-452.423-418.581-214.84-392.204-483.609-423.848-262.072-414.34-230.37-280.884-187.956-200.985-185.269-316.287-290.42
EBITDA Ratio -11,677.75-41,564.4-17,097.783-9,183.393-18,251.813-5,201.961-81.842-3,556.767-5,145.509-27.106-5,233.776-6,237.784-1,906.108-676.953-1,251.555-335.351-1,275.799-56.269-551.993-370.272-521.067-317.827-37.126-20.614-1.759-3.639-7.562-4.605-2.891-4.22-2.014-2.267-0.973-0.96-0.939-1.509-1.408